ライフサイエンスコーパス: beta1 receptor

1 eval in mutant mice lacking either NE or the beta1 receptor.

2 the beta2 receptor relative to that for the beta1 receptor.

3 These results establish alphavbeta1 as a LAP-beta1 receptor.

4 Inhibition of TGF-beta1 receptor 1 blocked Smad3 phosphorylation; reduced

5 1/2), and this was inhibited by blocking TGF-beta1 receptor 1, Smad3, or the Nox oxidases; ERK1/2 act

6 Stimulation of beta1 receptors and activation of the cAMP pathway lead

7 ct of propranolol on CCM is achieved through beta1 receptor antagonism.

8 ol (2 mug) or vehicle (Experiment 2), or the beta1-receptor antagonist, atenolol (Experiment 3).

9 activated within this pathway, alpha1 and/or beta1 receptors, are targets for clinically prescribed a

10 his signaling requires a functional integrin beta1 receptor as showed by RNA interference.

11 duration and with dogs with MR treated with beta1-receptor blockade (RB; extended-release metoprolol

12 se inhibitor), or practolol (10(-6) mol/L, a beta1-receptor blocker).

13 mice; (5) blockade of peripheral adrenergic beta1 receptors by atenolol potently attenuates the elev

14 with attenuated thermal hyperalgesia in TGF-beta1 receptor conditional knock-out mice, where TGF-bet

15 soluble fibronectin to cells via the alpha5 beta1 receptor decreased only about 3-fold.

16 ction covering 15 years in an interleukin-12 beta1 receptor-deficient individual that developed into

17 beta1-receptor downregulation also occurred in human PAH

18 ion-blocking antibodies directed towards the beta1 receptors dramatically reduced the tensional force

19 RYD sequence bound to macrophages and alpha4/beta1 receptor-expressing cells as well as did wild-type

20 lls, we demonstrate that IL-4 suppresses TGF-beta1 receptor expression and signaling, and vice versa.

21 internalize complexes of E-cadherin and TGF-beta1 receptors, generate phospho-Smad2 (p-Smad2)-pY654-

22 s blocked by a specific inhibitor of the TGF-beta1 receptor I and antibodies directed against alpha5

23 The levels of TGF-beta1 receptor II (TbetaRII) in adenovirus-infected cell

24 a1->Foxo1->TGF-beta1 looping by deleting TGF-beta1 receptor II in the liver or by blocking Foxo1-S273

25 CDA1 deletion reduced gene expression of TGF-beta1 receptors in the kidney, resulting in a functional

26 wley rats to determine the expression of TGF-beta1 receptors including endoglin, and the role of Ang

27 n, whereas downstream signaling from the TGF-beta1 receptor increased in both injured epithelium and

28 The specific TGF-beta1 receptor inhibitor SB431542 reduced ALI/ARDS BALF-

29 A TGF-beta1 receptor inhibitor, Rho-associated protein kinase

30 own receptors for OPN, and that the integrin beta1 receptor is involved in transmitting the prolifera

31 Inhibition of TGF-beta1 receptor kinase in HF MyoFb promotes dedifferentia

32 r if the latency-associated protein or a TGF-beta1 receptor kinase inhibitor was added to block the b

33 blocked by pre-incubation with a soluble TGF-beta1 receptor mimetic.

34 In intact failing hearts, downregulation of beta1-receptor mRNA and protein, upregulation of atrial

35 ifferent effects in patients with CYP2D6 and beta1-receptor polymorphisms.

36 Inhibiting beta1 receptors prevented the increase in glycinergic, b

37 Additionally, the TGF-beta1 receptor-regulated Smad proteins, in particular Sm

38 selective antagonists to visualize beta2 and beta1 receptors, respectively).

39 ts with the transforming growth factor (TGF)-beta1 receptor/smad phosphorylation inhibitor SB431542 i

40 mesenchymal transition without immediate TGF-beta1 receptor (TbetaR) kinase inhibition.

41 eta1 (TGF-beta1), transforming growth factor-beta1 receptor (TGF-beta1R), let-7a, and downstream expr

42 We established that Tif1gamma controls TGF-beta1 receptor (Tgfbr1) turnover.

43 to preferentially recognize ligand-occupied beta1 receptors was used to stain keratinocytes.

44 tin, in the GZ microenvironment via integrin beta1 receptors, which engages the Ras/Mapk cascade with